Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time-consuming and technically complex reference metho...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcia S. C. Melhem (Author), Vivian C. Coelho (Author), Claudia A. Fonseca (Author), Lidiane de Oliveira (Author), Lucas X. Bonfietti (Author), Maria. W. Szeszs (Author), Marcello M. C. Magri (Author), Francine S. Dorneles (Author), Hideaki Taguchi (Author), Daniel V. S. Moreira (Author), Adriana L. Motta (Author), Marjorie V. Batista (Author), Katsuhiko Kamei (Author), Maria A. Shikanai-Yasuda (Author)
Format: Book
Published: MDPI AG, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b16a7b5961b44a3e80b76ca3aa0be3a5
042 |a dc 
100 1 0 |a Marcia S. C. Melhem  |e author 
700 1 0 |a Vivian C. Coelho  |e author 
700 1 0 |a Claudia A. Fonseca  |e author 
700 1 0 |a Lidiane de Oliveira  |e author 
700 1 0 |a Lucas X. Bonfietti  |e author 
700 1 0 |a Maria. W. Szeszs  |e author 
700 1 0 |a Marcello M. C. Magri  |e author 
700 1 0 |a Francine S. Dorneles  |e author 
700 1 0 |a Hideaki Taguchi  |e author 
700 1 0 |a Daniel V. S. Moreira  |e author 
700 1 0 |a Adriana L. Motta  |e author 
700 1 0 |a Marjorie V. Batista  |e author 
700 1 0 |a Katsuhiko Kamei  |e author 
700 1 0 |a Maria A. Shikanai-Yasuda  |e author 
245 0 0 |a Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values 
260 |b MDPI AG,   |c 2022-10-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14102161 
500 |a 1999-4923 
520 |a Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time-consuming and technically complex reference methodologies. The Sensititre YeastOne (SYO) and Etest methods are widely utilized for yeasts but have not been extensively evaluated for <i>Aspergillus</i> isolates. We obtained Posaconazole (POS), Voriconazole (VCZ), Itraconazole (ITC), Amphotericin B (AMB), Caspofungin (CAS), and Anidulafungin (AND) minimum inhibitory concentrations (MICs) for both the Etest (<i>n</i> = 330) and SYO (<i>n</i> = 339) methods for 106 sequenced clinical strains. For 84 <i>A. fumigatus,</i> we analyzed the performance of both commercial methods in comparison with the CLSI-AFST, using available cutoff values. An excellent correlation could be demonstrated for Etest-AMB and Etest-VCZ (<i>p</i> < 0.01). SYO-MICs of AMB, VCZ, and POS resulted in excellent essential agreement (>93%), and >80% for AMB, VCZ, and ITC Etest-MICs. High categoric agreement was found for AMB, ITC, and CAS Etest-MICs (>85%) and AMB SYO-MICs (>90%). The considerable number of major/very major errors found using Etest and SYO, possibly related to the proposed cutoffs and associated with the less time-consuming processes, support the need for the improvement of commercial methods for <i>Aspergillus</i> strains. 
546 |a EN 
690 |a gradient diffusion assays 
690 |a <i>Aspergillus fumigatus</i> 
690 |a Etest 
690 |a CLSI 
690 |a Sensititre YeastOne 
690 |a azole antifungals 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 10, p 2161 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/10/2161 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/b16a7b5961b44a3e80b76ca3aa0be3a5  |z Connect to this object online.